Helping genetic medicines reach their full potential

A new layer of therapeutic DNA design, raising the ceiling of expression for improved durability, safety and cost effectiveness.

Scroll for more

Our Core Principles

We're combining synthetic biology and Ai to make sure life-changing medicines are viable and available to everyone

Learn more

what's the problem?

Genetic medicines are increasingly complex and synthetic. This means they hit an invisible ceiling. Therapeutic DNA is shut down by the cell's defence systems which have evolved to protect us from invading genetic material. This leads to fading performance and demands high doses, jeopardising cost effectiveness and patient safety.

what's the approach?

We have made world-first discoveries of novel gene silencing pathways responsible for turning off therapeutic DNA. Using proprietary first principles biology and machine learning AI, we redesign DNA to escape these pathways whilst preserving complete therapeutic function.

what's the outcome?

Our technology is agnostic to payload, delivery system and target cell. Our vision is to unlock the enormous potential of genetic medicines by ensuring they work forever in patients, are always safe and can be priced within willingness to pay thresholds.

The Science Behind Houdini Bio

Continue exploring our science

Dive deeper into the biology behind our platform, read our latest news, and explore resources including our white paper and company insights.

Explore Insights

what makes houdini bio?

Bypassing the cellular 'off switch'

The cell’s natural defences are a basic bottleneck. When a cell identifies new DNA as an intruder, it triggers a silencing switch that shuts it down before it can do its job.

Engineering DNA to be invisible

We don’t just tweak genes – we rewrite them from first principles. By removing the triggers that trip cellular alarms while keeping the biological instructions intact, we make the DNA invisible to natural defenses.

Creating durable, maximum impact

Our platform provides the control needed to ensure durable, high-level expression. By fixing this biological glitch, we enable life-changing treatments to work at lower doses, for longer.